Literature DB >> 21997780

The John Charnley Award: an accurate and sensitive method to separate, display, and characterize wear debris: part 1: polyethylene particles.

Fabrizio Billi1, Paul Benya, Aaron Kavanaugh, John Adams, Edward Ebramzadeh, Harry McKellop.   

Abstract

BACKGROUND: Numerous studies indicate highly crosslinked polyethylenes reduce the wear debris volume generated by hip arthroplasty acetabular liners. This, in turns, requires new methods to isolate and characterize them. QUESTIONS/PURPOSES: We describe a method for extracting polyethylene wear particles from bovine serum typically used in wear tests and for characterizing their size, distribution, and morphology.
METHODS: Serum proteins were completely digested using an optimized enzymatic digestion method that prevented the loss of the smallest particles and minimized their clumping. Density-gradient ultracentrifugation was designed to remove contaminants and recover the particles without filtration, depositing them directly onto a silicon wafer. This provided uniform distribution of the particles and high contrast against the background, facilitating accurate, automated, morphometric image analysis. The accuracy and precision of the new protocol were assessed by recovering and characterizing particles from wear tests of three types of polyethylene acetabular cups (no crosslinking and 5 Mrads and 7.5 Mrads of gamma irradiation crosslinking).
RESULTS: The new method demonstrated important differences in the particle size distributions and morphologic parameters among the three types of polyethylene that could not be detected using prior isolation methods.
CONCLUSION: The new protocol overcomes a number of limitations, such as loss of nanometer-sized particles and artifactual clumping, among others. CLINICAL RELEVANCE: The analysis of polyethylene wear particles produced in joint simulator wear tests of prosthetic joints is a key tool to identify the wear mechanisms that produce the particles and predict and evaluate their effects on periprosthetic tissues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21997780      PMCID: PMC3254734          DOI: 10.1007/s11999-011-2057-x

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  47 in total

1.  Isolation and characterization of UHMWPE wear particles down to ten nanometers in size from in vitro hip and knee joint simulators.

Authors:  J L Tipper; A L Galvin; S Williams; H M J McEwen; M H Stone; E Ingham; J Fisher
Journal:  J Biomed Mater Res A       Date:  2006-09-01       Impact factor: 4.396

Review 2.  Clinical performance of highly cross-linked polyethylenes in total hip arthroplasty.

Authors:  Cale A Jacobs; Christian P Christensen; A Seth Greenwald; Harry McKellop
Journal:  J Bone Joint Surg Am       Date:  2007-12       Impact factor: 5.284

3.  Identification of nanometre-sized ultra-high molecular weight polyethylene wear particles in samples retrieved in vivo.

Authors:  L Richards; C Brown; M H Stone; J Fisher; E Ingham; J L Tipper
Journal:  J Bone Joint Surg Br       Date:  2008-08

4.  Five-year comparative study of highly cross-linked (crossfire) and traditional polyethylene.

Authors:  Amar D Rajadhyaksha; Cristian Brotea; Yeukkei Cheung; Courtney Kuhn; Rama Ramakrishnan; Steven B Zelicof
Journal:  J Arthroplasty       Date:  2008-03-04       Impact factor: 4.757

5.  Reduction of osteolysis with use of Marathon cross-linked polyethylene. A concise follow-up, at a minimum of five years, of a previous report.

Authors:  Rudi G Bitsch; Travis Loidolt; Christian Heisel; Scott Ball; Thomas P Schmalzried
Journal:  J Bone Joint Surg Am       Date:  2008-07       Impact factor: 5.284

Review 6.  Periprosthetic osteolysis: an immunologist's update.

Authors:  R John Looney; Edward M Schwarz; Allen Boyd; Regis J O'Keefe
Journal:  Curr Opin Rheumatol       Date:  2006-01       Impact factor: 5.006

7.  Crosslinked polyethylene compared to conventional polyethylene in total hip replacement: pre-clinical evaluation, in-vitro testing and prospective clinical follow-up study.

Authors:  Carel H Geerdink; Bernd Grimm; Rama Ramakrishnan; Jorco Rondhuis; Aart J Verburg; Alphons J Tonino
Journal:  Acta Orthop       Date:  2006-10       Impact factor: 3.717

8.  Incidence and volume of pelvic osteolysis at early follow-up with highly cross-linked and noncross-linked polyethylene.

Authors:  Serena B Leung; Hiroshi Egawa; Adam Stepniewski; Sarah Beykirch; C Anderson Engh; Charles A Engh
Journal:  J Arthroplasty       Date:  2007-07-27       Impact factor: 4.757

9.  Highly crosslinked vs conventional polyethylene particles: relative in vivo inflammatory response.

Authors:  Richard Lynn Illgen; Lia M Bauer; Bryan T Hotujec; Sarah E Kolpin; Aleem Bakhtiar; Todd M Forsythe
Journal:  J Arthroplasty       Date:  2008-04-10       Impact factor: 4.757

10.  Cross-linked compared with historical polyethylene in THA: an 8-year clinical study.

Authors:  Carel H Geerdink; Bernd Grimm; Wendy Vencken; Ide C Heyligers; Alphons J Tonino
Journal:  Clin Orthop Relat Res       Date:  2008-11-22       Impact factor: 4.176

View more
  3 in total

1.  The John Charnley Award: Highly crosslinked polyethylene in total hip arthroplasty decreases long-term wear: a double-blind randomized trial.

Authors:  Siôn Glyn-Jones; Geraint E R Thomas; Patrick Garfjeld-Roberts; Roger Gundle; Adrian Taylor; Peter McLardy-Smith; David W Murray
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

2.  The biological response to nanometre-sized polymer particles.

Authors:  Aiqin Liu; Laura Richards; Catherine L Bladen; Eileen Ingham; John Fisher; Joanne L Tipper
Journal:  Acta Biomater       Date:  2015-05-22       Impact factor: 8.947

3.  Mixed material wear particle isolation from periprosthetic tissue surrounding total joint replacements.

Authors:  Ashley A Stratton-Powell; Sophie Williams; Joanne L Tipper; Anthony C Redmond; Claire L Brockett
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2022-05-09       Impact factor: 3.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.